Active, not recruitingNo phase
CHAMP T 2 Pilot of CIMT by Tele-Video
Key facts
- Who runs it
- Warren Lo
- Where
- Columbus and Roanoke, United StatesSee the 2 sites
- Trial code
- Status
- Active, not recruiting
- People taking part
- 10 people, planned
- Started
- 27 Jun 2024
- Expected to end
- 30 Jun 2027
- Type of study
- Interventional
- Treatments tested
- Constraint induced movement therapy delivered by televideo
- Record updated
- 23 December 2025
Who can take part
- Age
- 4 years to 10 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 11 criteriaShow less
Who can take part
- Children who have hemiplegic cerebral palsy, ages 4-10
- hemiparesis ranging from Manual Ability Classification System (MACS) I to MACS IV
- live within a 1.5 hour distance from therapists' worksites at the Ohio State University Wexner Medical Center in Columbus, Ohio, or the Fralin Biomedical Research Institute in Roanoke, Virginia
- are willing to travel to these sites for two in-person assessments
Who cannot take part
- Previous high dose CIMT (defined as CIMT given 2 hrs per day for 10 days) in the 6 months preceding baseline assessment
- Treatment with botulinum toxin for spasticity in the 3 months preceding baseline assessment
- Surgery for spasticity in the 6 months preceding baseline assessment
- Medically unstable and unable to participate in the treatment intervention
- Child is behaviorally or cognitively impaired so unable to participate in the treatment intervention
- Family unable to participate in tele-delivery of CIMT 5 days a week for 4 weeks
- the caregiver available at child's treatment site during treatment times is unable to communicate with the treating therapist
Where in United States
- The Ohio State University School of Health and Rehabilitation SciencesColumbus, United StatesNo longer taking part
- Virginia Tech-Fralin Biomedical Research InstituteRoanoke, United StatesNo longer taking part
About the trial
What the trial wants to find out
The CHAMP-T2 study is a pilot test of the efficacy of constraint induced movement therapy (CIMT) when delivered by tele-video in the child's home or home-like environment. This study will examine the pre-, post-intervention function a hemiparetic limb in children who have hemiplegic cerebral palsy. The purpose is to provide an effect size estimate that will inform the design of a future study that will compare tele-delivered CIMT with usual and customary care.
The group in the trial
- Intervention armTreatment being tested
This is a single arm in an open label pre- post-treatment design to estimate effect size of the intervention
Treatment: Constraint induced movement therapy delivered by televideo
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Efficacy of Constraint Induced Movement Therapy Delivered by Tele-Video for Children With Hemiplegic Cerebral Palsy
- Record updated
- 23 December 2025